Evidence map›Paper›PMID 40575576›Full record

ArticleFrontiers in medicine2025

Machine learning-based prediction of carotid intima-media thickness progression: a three-year prospective cohort study.

An Zhou, Kui Chen, Yonghui Wei, Qu Ye, Yuanming Xiao, Rong Shi, Jiangang Wang, Wei-Dong Li

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

An Zhou *Department of Genetics, College of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Kui Chen *Health Management Medical Center, Third Xiangya Hospital, Central South University, Changsha, China.
Yonghui Wei *Department of Genetics, College of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Qu Ye *Department of Genetics, College of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Yuanming Xiao *Health Management Medical Center, Third Xiangya Hospital, Central South University, Changsha, China.
Rong ShiDepartment of Genetics, College of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Jiangang WangHealth Management Medical Center, Third Xiangya Hospital, Central South University, Changsha, China.
Wei-Dong LiDepartment of Genetics, College of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early detection of subclinical atherosclerosis progression is crucial for preventing atherosclerotic cardiovascular disease (ASCVD). Carotid intima-media thickness (CIMT) is a recognized surrogate marker for atherosclerosis, but accurate prediction of its progression remains challenging. This study aimed to develop and validate machine learning models for predicting CIMT progression via routine clinical biomarkers. Methods: In this three-year prospective cohort study, we analyzed data from 904 participants from the Third Xiangya Hospital of Central South University Health Examination Cohort who underwent three consecutive annual CIMT measurements. The participants were categorized into CIMT thickening and nonthickening groups on the basis of a final CIMT ≥1.0 mm or an increase ≥0.1 mm across consecutive measurements. We evaluated seven machine learning algorithms: logistic regression, random forest, XGBoost, support vector machine (SVM), elastic net, decision tree, and neural network. Model performance was assessed through discrimination (AUC, sensitivity, specificity) and calibration metrics, with Platt scaling applied to optimize probability estimates. Clinical utility was evaluated through decision curve analysis. Results: Compared with the more complex algorithms, the elastic net model demonstrated superior performance (AUC 0.754). Baseline CIMT, absolute monocyte count, sex, age, and LDL-C were identified as the most influential predictors. After Platt scaling, the calibration improved significantly across all the models. Decision curve analysis revealed a positive net benefit across a wide threshold range (0.01-0.5). On the basis of calibrated probabilities, we developed a three-tier risk stratification framework that identified distinct groups with progressively higher event rates: medium-risk (13.9%), high-risk (50.0%), and very-high-risk (60.0%). Subgroup analysis revealed better predictive performance in younger participants (<50 years), those with lower baseline CIMT (<0.8 mm), and females. Conclusion: Machine learning approaches, particularly the elastic net model, can effectively identify individuals at high risk for CIMT progression via routine clinical biomarkers. The superior performance of simpler models suggests predominantly linear relationships between predictors and CIMT progression. Following appropriate calibration, the model demonstrated strong clinical utility across diverse decision thresholds, supporting a stratified approach to atherosclerosis prevention.

Indexed as

atherosclerosis progressioncardiovascular preventioncarotid intima–media thickness (CIMT)machine learningrisk prediction

Identifiers

PMID40575576
PMCPMC12198118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.